跳至主要内容
临床试验/NCT01841450
NCT01841450Unknown不适用

A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery

Glaukos Corporation14 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2013年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
360
试验地点
14
主要终点
Rate of sight-threatening adverse events

研究概览

简要总结

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate open-angle glaucoma.

详细描述

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery compared to cataract surgery only, in subjects with mild to moderate open-angle glaucoma.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •mild to moderate primary open-angle glaucoma
  • •currently treated with ocular hypotensive medication
  • •pseudoexfoliative and pigmentary glaucoma are acceptable diagnoses
  • •subject scheduled to undergo cataract surgery

排除标准

  • •primary angle-closure glaucoma; or secondary angle closure glaucoma, including neovascular glaucoma
  • •retrobulbar tumor, thyroid eye disease, Sturge-Weber syndrome or any other type of condition that may cause elevated episcleral venous pressure

研究组 & 干预措施

iStent

Experimental

Implantation of one iStent in conjunction with cataract surgery

干预措施: iStent (Device)

Cataract surgery

Active Comparator

Cataract surgery alone

干预措施: Cataract surgery (Procedure)

结局指标

主要结局

Rate of sight-threatening adverse events

时间窗: 36 months

次要结局

  • Other adverse events(36 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

Multicenter Post-Approval Study Of The Glaukos®... | 临床试验